Effect of plant extracts on Alzheimer's disease: An insight into therapeutic avenues - PubMed (original) (raw)

Effect of plant extracts on Alzheimer's disease: An insight into therapeutic avenues

M Obulesu et al. J Neurosci Rural Pract. 2011 Jan.

Abstract

Alzheimer's disease (AD) is a devastative neurodegenerative disorder which needs adequate studies on effective treatment options. The extracts of plants and their effect on the amelioration of AD symptoms have been extensively studied. This paper summarizes the mechanisms like acetylcholinesterase (AChE) inhibition, modification of monoamines, antiamyloid aggregation effect, and antioxidant activity which are actively entailed in the process of amelioration of AD symptoms. These effects are induced by extracts of a few plants of different origin like Yizhi Jiannao, Moringa oleifera (Drumstick tree), Ginkgo Biloba (Ginkgo/Maidenhair tree), Cassia obtisufolia (Sicklepod), Desmodium gangeticum (Sal Leaved Desmodium), Melissa officinalis (Lemon Balm), and Salvia officinalis (Garden sage, common sage).

Keywords: Alzheimer's disease; acetyl choline esterase inhibitors; antiamyloid aggregation; antioxidants; plant extracts..

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Similar articles

Cited by

References

    1. Kim JK, Bae H, Kim MJ, Choi SJ, Cho HY, Hwang HJ, et al. Inhibitory effect of poncirus trifoliate on acetyl cholinesterase and attenuating activity against trimethyltin induced learning and memory impairment. Biosci Biotechnol Biochem. 2009;73:1105–12. - PubMed
    1. Heo HJ, Kim MJ, Lee JM, Choi SJ, Cho HY, Hong BS, et al. Naringenin from Citrus junos has an inhibitory effect on acetylcholinesterase and a mitigating effect on amnesia. Dement. Geriatr. Cogn Disord. 2004;17:151–7. - PubMed
    1. Prasad KN, Hovland AR, Cole WC, Prasad KC, Nahreini P, Edwards-Prasad J, et al. Multiple antioxidants in the prevention and treatment of Alzheimer disease: Analysis of biologic rationale. Clin Neuropharmacol. 2000;23:2–13. - PubMed
    1. Terry RD, Masliah E. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991;30:572–80. - PubMed
    1. Candy JW, Perry RH, Perry EK, Irving D, Blessed G, Fairbairn AF. Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases. J Neurol Sci. 1983;59:277–89. - PubMed

LinkOut - more resources